Fish & Richardson P.C.
Methods for isolating and proliferating autologous cancer antigen-specific CD8+T cells
Provided is a method for isolating and proliferating autologous cancer antigen-specific CD8+ T cells, and more particularly, a method for selecting an epitope recognized by CD8+ T cells from autologous cancer antigens present in blood of individual cancer patients; and isolating autologous cancer antigen-specific CD8+ T cells by using a peptide of the selected epitope, and a method of massively proliferating CD8+ T cells by using the method. According to the present invention, it is possible to isolate autologous cancer antigen-specific CD8+ T cells by using the peptide of the CD8 T cell epitope of the autologous cancer antigen present in blood of individual cancer patients instead of a heterologous antigen. Therefore, by using T cells recognizing the autologous cancer antigen, it is possible to effectively select and eliminate cancer cells derived from the cancer patient's own cells. Thus, T cells can be applied to treatment and alleviation of cancer diseases without side effects.
Eutilex Co., Ltd.
C C C C C C
C12N C12N C12N C12N C12N C12N
inventional additional additional inventional additional additional
Don-Gil Young Ho Young-Woo Sang-Yoon Seung-Hoon Kwang-Hui Sang-Jae Hyeon-Seok Beom-Kyu Young-Joo Byung-Kiu Byoung S. Heon Jin-Soo Ho-Sik Hyun-Guy
Lee Kim Kim Park Lee Kim Park Eom Choi Lee Park Kwon Yoo Lee Oh Kang